title: [NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
abstract: Invasive fungal infections are increasing due to the increase in the number of at risk patients. The antifungal armamentarium has been improved the last few years with new galenic for ampoetericin B, the widening of the azole spectrum with voriconazole, poscaonazole and isavuconazole and the launch of a new antifungal class, the eschinocandins, currently represented by casoefungin and micftungin. The aim of this work is to provide an update in new antifungal drugs available.
authors.forename: Benoît
authors.initials: B
authors.lastname: Pilmis
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
authors.forename: Fanny L
authors.initials: FL
authors.lastname: Lanternier
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D000077336:Caspofungin; D004358:Drug Therapy / Q000639:trends; D054714:Echinocandins / Q000627:therapeutic use; D006801:Humans; D055666:Lipopeptides / Q000627:therapeutic use; D000077551:Micafungin; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D009570:Nitriles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D009570:Nitriles; D011725:Pyridines; D014230:Triazoles; C508735:isavuconazole; C101425:posaconazole; D000077336:Caspofungin; D065819:Voriconazole; D000077551:Micafungin